Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,028 across all filing types
Latest filing 2024-11-27 Proxy Solicitation & In…
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Proxy Solicitation & Information Statement 2024
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Statement filed on Schedule 14A with the SEC, as indicated by the header and form type. It is related to a Special Meeting of Stockholders for Enveric Biosciences, Inc. The content includes details about the meeting, proposals to be voted on (including a reverse stock split), voting instructions, and other shareholder meeting materials. Proxy Statements are materials sent to shareholders to provide information and solicit votes for meetings. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains detailed proxy information, not just an announcement or notice, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is PSI with high confidence.
2024-11-27 English
Delisting Announcement 2024
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 20, 2024, by Enveric Biosciences, Inc. The content focuses on a delisting notice from Nasdaq due to failure to meet the minimum bid price requirement and the company's intention to appeal this determination. The document discusses regulatory compliance and listing status rather than financial results or management changes. It is not an annual or quarterly report, earnings release, or management discussion. The primary subject is the official notice of delisting and related procedural information. Therefore, the document fits the category of a Delisting Announcement (DLST). The document length is 5801 characters, sufficient to contain substantive detail about the delisting event.
2024-11-22 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q3 2024
2024-11-14 English
Earnings Release 2024
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 14, 2024, by Enveric Biosciences, Inc. It announces the issuance of a press release providing a corporate update and financial results for the third quarter ended September 30, 2024. The document explicitly states that the press release is furnished as Exhibit 99.1 and incorporated by reference. The text does not contain the actual financial statements or detailed financial data but rather announces the release of such information. The document length is 4295 characters, which is relatively short and consistent with an announcement rather than a full report. According to the "Menu vs Meal" rule, this is an announcement of financial results, not the full earnings release itself. Therefore, the appropriate classification is Earnings Release (ER), as Form 8-K Item 2.02 is typically used for earnings announcements and financial results disclosures.
2024-11-14 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-14 English
AMENDMENT NO. 3 TO SCHEDULE 13G
Major Shareholding Notification
2024-11-13 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.